US-based drugs company Eli Lilly has promoted Darren Carroll to senior vice president of corporate business.
Carroll had been vice president of corporate business development since 2010, having originally joined Eli Lilly as an attorney in 1996. He was appointed vice president of new ventures in 2005 and has subsequently managed investments for corporate venturing units Lilly Ventures and Lilly Asia Ventures.
Carroll was named on Global Corporate Venturing’s Powerlist in 2012, 2013 and 2014.
In his new role as senior vice president, Carroll will be in charge of all strategic corporate venturing efforts including mergers and acquisitions, joint ventures, business collaborations, private equity investments and out-partnering. He will report to Derica Rice, the company’s executive vice president of global services and chief financial officer.
Carroll said: “The companies that are most effective at external innovation leverage a strong internal innovation capability. Our long term commitment to scientific excellence at Lilly is the foundation for success in identifying, accessing and shaping external innovation.
“It has been recognised by partners that range from startups to other top 10 pharmaceutical companies, and it is a critical reason why we are attractive as a partner: We are all in on innovation.”
– Photo of Darren Carroll courtesy of Eli Lilly